Iradimed Corp. (IRMD) Tops Q2 EPS by 2c; Issues Confident Q3 Outlook, Boosts FY15 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
IRADIMED CORPORATION Announces Second Quarter 2015 Financial Results
July 30, 2015 7:30 AM EDTRevenue grows 62% compared to the same quarter last year Reports second quarter 2015 non-GAAP diluted EPS of $0.16 Increases full year 2015 revenue and non-GAAP earnings guidance Announces third quarter financial guidance
WINTER SPRINGS, Fla., July 30, 2015 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended June 30, 2015.Â
For the second quarter ended June 30, 2015, the Company reported revenue of $7.6... More
